MarginsXMarginsX
Home › Data Desk › Vir Biotechnology Inc. puts a 424B5 prospectus supplement on file

MarginsX Data Desk · Offerings · Dilution · Oncology · Early-stage clinical trials · Licensing and milestone payments

Vir Biotechnology Inc. puts a 424B5 prospectus supplement on file

On Nov 16, 2026, Vir Biotechnology Inc. (VIR) filed a 424B5: a prospectus supplement for a sale from its shelf. (SEC EDGAR, 424B5, Nov 16, 2026)

By the MarginsX Data Desk, automated. Published November 16, 2026. Data as of November 16, 2026.

Line chart of Vir Biotechnology Inc. (VIR) daily closes from Jul 9, 2026 to Nov 13, 2026, with the offering filing on Nov 16, 2026 marked.

Cash and dilution

It reported cash of $218.9M as of Sep 30, 2026. (Company health, computed by us from SEC filings and XBRL, Sep 30, 2026)

At its recent quarterly burn rate that cash lasts about 18.6 months, by our estimate from its XBRL cash flows. (Company health, computed by us from SEC filings and XBRL, Sep 30, 2026)

Its share count rose 23.1% over the past year. (Company health, computed by us from SEC filings and XBRL, Oct 28, 2026)

Our count of its shelf registrations over the past twelve months is 1. (Company health, computed by us from SEC filings and XBRL, Nov 12, 2026)

Our count of its prospectus takedowns over the same months is 3. (Company health, computed by us from SEC filings and XBRL, Nov 12, 2026)

The stock

The Nasdaq screener puts its market value at $1.7B. (Nasdaq stock screener, Nov 13, 2026)

Vir Biotechnology Inc. files a 424B5 prospectus supplement

Vir Biotechnology Inc. (VIR) filed a 424B5 on Nov 16, 2026, a prospectus supplement for a sale from its shelf. (SEC EDGAR, 424B5, Nov 16, 2026)

Follow it up

The company's page on MarginsX, with its filings, health check and ownership. (capital.sophiaxt.com/stocks/VIR)

The filing on SEC EDGAR. (sec.gov)

Automated from SEC filings and market data by the MarginsX Data Desk, written by template with no AI. For information only. Not investment advice.

Facts behind this article

FactValueSourceAs of
NameVir Biotechnology Inc.Source2026-11-13
Form424B5Source2026-11-16
FiledNov 16, 2026Source2026-11-16
WhoVir Biotechnology Inc. (VIR)Source2026-11-13
SymbolVIRSource2026-11-13
Cash218,866,000 USDSource2026-09-30
Cash dateSep 30, 2026Source2026-09-30
Runway18.6 monthsSource2026-09-30
Dilution 1y23.1 %Source2026-10-28
Shelves 12m1Source2026-11-12
Takedowns 12m3Source2026-11-12
Cap1,705,856,899 USDSource2026-11-13

Sources

Automated from SEC filings and market data. No AI. For information only. Not investment advice.

Discuss in MarginsX More from the Data Desk

More on MarginsX

Companies in this article

Topics

Related Data Desk stories

Every Data Desk article: /desk · RSS